Mahamaya Lifesciences IPO Review & Recommendations

Bookbuilding IPO | ₹70 Cr | Listed at BSE SME | Tue, Nov 11, 2025 - Thu, Nov 13, 2025

IPO Recommendations (0 Reviews)

Review ByApplyMay ApplyNeutralAvoidNot Rated
Count00000
%00000

Mahamaya Lifesciences IPO Peer Comparison

Mahamaya Lifesciences Ltd. peer comparison with similar listed entities. (As on March 31, 2025)

Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)P/BV RatioFinancial statements
Mahamaya Lifesciences Limited7.607.6027.8226.19Consolidated
Nova Agritech Limited3.053.0523.7616.9312.472.22Consolidated
Bhagiradha Chemicals & Industries Ltd.1.141.1452.61247.632.035.42Consolidated

Notes:

  1. P/E figures for the peer are based on closing market prices of equity shares on BSE on August 20, 2025 divided by the Basic EPS as at March 31, 2025.
  2. Basic and Diluted EPS refers to the Basic and Diluted EPS sourced from the Annual Report for the FY 24-25 of the listed peer company.
  3. Return on Net Worth (%) for listed peer companies has been computed based on the Net Profit After Tax for the year ended March 31, 2025 divided by Total Equity as on March 31, 2025.
  4. NAV per share for listed peer companies is computed as the networth as on March 31, 2025 divided by the outstanding number of equity shares as on March 31, 2025

IPO Review by Members

Mahamaya Lifesciences IPO Reviews, analysis and views by popular members.

Review ByApplyMay ApplyNot RatedAvoid
Count0000
%0.000.000.000.00
MemberReview
No recommendation found. Be the first to post the recommendation.

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.
Open an Instant Account with Zerodha